The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of heterozygous UGT1A1*28 genotype on toxicity, dose-intensity and treatment compliance in pancreatic cancer patients receiving FOLFIRINOX/mFOLFIRINOX.
 
Riccardo Bacalini
No Relationships to Disclose
 
Pasqualina Castaldo
No Relationships to Disclose
 
Carolina Liguori
No Relationships to Disclose
 
Elisa Tiberi
No Relationships to Disclose
 
Alessandro Parisi
No Relationships to Disclose
 
Simona Magi
No Relationships to Disclose
 
Agnese Secondo
No Relationships to Disclose
 
Silvia Piccirillo
No Relationships to Disclose
 
Rossana Berardi
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Eisai; GlaxoSmithKline; Lilly; Menarini; Roche (Inst)
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Roche (Inst)
 
Riccardo Giampieri
Consulting or Advisory Role - AstraZeneca; Merck; MSD